Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gene Mack Insider Profile
4 Followers
Gene Mack, CFO and Interim CEO at Gain Therapeutics, holds 14.40K shares in Gain Therapeutics (Ticker: GANX). Most recently, Gene Mack Bought $14,400 shares of Gain Therapeutics on Aug 12, 2024 for an estimated value of 14.54K.
Gene Mack has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CFO and Interim CEO
Roles that Gene Mack holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Gene Mack
Gene Mack's Trading History
List of latest transactions for each holding click on a transaction to see Gene Mack's performance on stock
You May Also Like
Gene Mack insider profile FAQ
What is the percentage of profitable transactions made by Gene Mack?
The percentage of profitable transactions made by Gene Mack is ―.
What is the average return per transaction made by Gene Mack?
The average return per transaction made by Gene Mack is ―.
What stocks does Gene Mack hold?
Gene Mack holds: GANX stocks.
What was Gene Mack’s latest transaction?
Gene Mack latest transaction was an Informative Buy of $14.54K.
What was Gene Mack's most profitable transaction?
Gene Mack’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Gene Mack's role in Gain Therapeutics?
Gene Mack's role in Gain Therapeutics is CFO and Interim CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.